Research progress on sensitive genes related to ferroptosis

WU Hao-lin, XU Yi-qian, FANG Xing-yue, WANG Ai-ping, MENG Qing-wen, LIU Qibing,FAN Hao-fei

1.Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, Haikou 571199, China

2.Department of Pharmacology, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou 571199, China

Keywords:

ABSTRACT

1.Introduction

Ferroptosis phenomenon was first discovered by Sonam et al in 2003, and formally named by Dixon in 2012, mainly a new form of procedural cell death catalyzed by abnormal lipid oxide metabolism in cells[1].In 2021, Yao et al found that Ferroptosis played an important role in neurological diseases such as cerebral hemorrhage,ischemic stroke, neurodegenerative diseases, and cardiovascular and cerebrovascular diseases[2]Among neuron Ferroptosis is closely related to neurological disease and hemorrhagic stroke,cerebral cytolysis causes hemoglobin release, hemoglobin further decomposed into heme and its oxidation form of heme chloride,induce Ferroptosis[2].Meanwhile, in cancer treatment studies,cancer cells grow a higher iron demand than normal cells, therefore,triggering Ferroptosis sensitive related genes, targeted induction of Ferroptosis has a good advantage[3].It can be speculated that cancer death can induce differentiated death and avoid normal cells.Second, inhibiting different Ferroptosis sensitive genes can reduce neuronal damage and protect the nervous system.Therefore, how to regulate Ferroptosis sensitive genes, effectively or directional induce or inhibit Ferroptosis, play a differentiated damage or protective role is particularly important.This paper mainly summarizes the known genes related to Ferroptosis sensitivity and its induction mechanism to provide reliable clues for Ferroptosis in disease treatment or prevention research.

2.Regulates Ferroptosis-related genes inducing Ferroptosis

Ferroptosis is genetically regulated, And showed the various metabolic changes, Depending on the protein metabolic pathway,Ferroptosis-related genes are divided into four categories: iron metabolism: ACO1, CISD1/mitto NEET, FANCD2, FTH 1, HMOX1,HSBP1, IREB2, NCOA4, NFS1, PHKG2, STEAP3, TFRC; Lipid metabolism: ACSF2, ACSL4, CS, GPX4, LOX, LPCAT3, PEBP1;Antioxidative metabolism: MRP1, CARS, CBS, GCLC, HMOX1,KEAP1, NOX, NQO1, NRF2, SLC7A11; Energy metabolism: G6PD,GLS2, GOT1, microRNA 137, SLC1A5, Its function and regulation effects are shown in Table 1.Currently recognized and most reported regulatory Ferroptosis sensitive related genes include inhibition of glutathione peroxidase 4 (GPX4), FSP1, SLC7A11, P53, etc[4].

Tab1 List of ferroptosis-related genes

2.1 The GPX4 gene

G PX4 protein is an important lipid repair enzyme in the human body, which plays an important function in producing lipid messenger molecular pathways, mainly responsible for the degradation of lipid peroxide, removing toxic intermediates, and is regarded as a key regulator for Ferroptosis[4].GPX4 protein resists both iron and oxygen-dependent lipid peroxidation by converting a lipid peroxide (LOOH) into a non-toxic lipid[4].Glutathione (GSH)An important intracellular antioxidant synthetic from glutamate,cysteine and glycine, is a cofactor and synthetic substrate of GPX4 protein, essential for GPX4 protein to play a lipid repair function[33].By inhibiting System XC-causing cysteine consumption and lack of GSH synthetic substrate, thereby weakening the antioxidant enzyme GPX4 protein function, eventually resulting in oxygen homeostasis imbalance in somatic cells, inducing Ferroptosis[34].Recent studies have shown that cancer recurrence from resistant cancer cells is closely related to Ferroptosis, and Ferroptosis occurrence can remove cancer cells that escape treatment, thus providing an effective strategy to prevent cancer recurrence[35].Among them, GPX4 is considered a sensitive gene and important target for resistant cancer cells through Ferroptosis killing, with inducers Erastin, Imidazole ketone erastin (IKE), azazpyridine[36-43], See Table 2.

After the death of iron, the expression of its sensitive gene GPX4 is necessarily downregulated.In 2019, Zou Y et al found in renal transparent cell cancer studies that HIF-2 through hypoxia-induced activation of lipid drop-related protein (HILPDA) expression,inhibited GPX4 gene expression, resulting in reduced GPX4 protein synthesis, promoting polyunsaturated lipid aggregation,thus increasing transparent cell cancer sensitivity to Ferroptosis[44].In 2021 Thayyullathil F et al.found that GSH scavenger Erastin inhibited System XC-, on the plasma membrane by reduced cell ability to acquire cysteine, reduced cysteine synthesis, and in turn triggered membrane lipid ROS accumulation and Ferroptosis[45].Furthermore, Lee N et al.found that another GPX4 inhibitor, RSL3,could also induce cell lipid oxidation and Ferroptosis[46].Wei Z et al.found that RSL3 (0.1 M) could significantly induce the death of human lens epithelial cells and lens epithelial iron in mice, both in vitro and in vitro[34].More research has shown that the Ferroptosissensitive gene GPX4, may target the Ferroptosis, providing reference for the research and development of targeted anti-tumor or protective cell drugs.

2.2 The FSP1 gene

FSP1 was originally known as mitochondrial Apoptosis Induction Inductive Factor 2 (Apoptosis-inducing factor mitochondrial 2,AIFM2) and was named due to the sequence similarity to apoptosisrelated factor AIFM1[47].FSP1 is an Ferroptosis sensitive related gene where overexpression in cells can significantly protect cells from Ferroptosis inductor factors[47].This is the first discovery of an enzyme catalytic system to compensate for GPX4 deficiency[48]In 2019, both German and American groups found that FSP1 cardamylation was critical to inhibit Ferroptosis[47,48].FSP1 protein prevents lipid oxidation by reducing the coenzyme-Q10 (CoQ10),thereby inhibiting Ferroptosis[48].In 2020, Wu Warren found that FSP1 and GPX4 proteins were involved in non-interference inhibition, which used CRISPR-Cas9 screening to identify Ferroptosis suppression protein FSP1 as an effective Ferroptosis resistance factor[49].Data show that cartmeg acylation raises FSP1 into the mass film, becomes redox, reduces CoQ10 levels,generates lipophilic free radical capture antioxidants (RTA) and avoiding lipid peroxidation[48].The Researchers further found that FSP1 gene expression was positively associated with Ferroptosis resistance in hundreds of cancer cell lines and found resistance to Ferroptosis in FSP1 protein-mediated cultured lung cancer cells and tumor allografts in mice[47].Thus, these data determine that FSP1 is a critical component of the non-mitochondrial CoQ antioxidant system, independently promoting Ferroptosis occurrence based on the GSH classical GPX4 pathway.To explore other inhibitors of Ferroptosis, Zhang et al used the CRISPR/Cas9 method for genome-wide screening, finding that when the FSP1 gene was knocked out, the tumor cell resistance to RSL3 disappeared and the degree of Ferroptosis increased[50].It is shown that pharmacological targeting of FSP1 gene and GPX4 inhibitors induce Ferroptosis[48].In summary, FSP1/CoQ10/NAD (P) H acts as a single parallel induction system works in collaboration with GPX4 and GSH to inhibit phospholippid peroxidation (pLPO) and Ferroptosis.

2.3 The SLC7A11 gene

SystemXC-encoded by the SLC7A11 gene belongs to the family of isodimic amino acid transporters, has the function of exchanging L-cysteine and L-glutamate and is considered to be one of the major signaling pathways associated with Ferroptosis[51].Glusteine is exchanged at 1: 1, so glutamate levels affect systemXCfunction[52].Extracellular high concentrations of glutamate inhibit SystemXC-and induce Ferroptosis.Mice knocking off systemXCcan prevent neurotoxic damage due to reduced extracellular glutamate levels[53].Erastin can act as an iron-promoting death trigger, inhibiting SystemXC-function and consuming GSH, by eventually inactivating GPX4, causing lipid peroxide accumulation,which further leads to an increase in ROS[53].Cyclic iron trivalent iron ion (Fe3+) Introducing cells through the ferrin receptor (TFR),then converted into Fe2+in the inner body [54].Fe2+Overdose causes lipid ROS accumulation through Fenton reaction, resulting in turn Ferroptosis[54].

2.4 The P53 gene

Tumor suppressor protein p53 (TP53) is a stress response transcription factor capable of activating multiple target genes under different stress conditions, including oxidative stress, genotoxic damage, oncogene activation, and hypoxia[55].p53 gene expression can significantly stimulate biological functions such as cell cycle block, apoptosis, aging, metabolism, and autophagy regulation[28].p53 protein was found in the 1970 s and plays a key role in cells to various stress responses including DNA damage, hypoxia,nutritional hunger, and oncogene activation[56].In 2015, XX first found that p53 increased sensitivity to Ferroptosis by inhibiting SLC7A11 expression, and[57].Li S et al.showed increased P53 expression in 1-methyl-4-phenylpyridine (MPP) induced Ferroptosis cell models, resulting in reduced 7 members of the solute carrier family 11 (SLC7A11) and GPX4 expression[28].Hong T et al found Ferroptosis in mutant ovarian cancer, the main mechanism may be p53-dependent downof SLC7A11 expression[58].

Studies have shown that p53 protein activation inhibits SLC7A11 transcription, resulting in reduced cysteine intake, reduced intracellular GSH, increased ROS levels, and lipid peroxidation[28].Thus, increased ROS-induced Ferroptosis sensitivity in p53-activated cells[28].The p53 mutant (p53 KR) cannot induce cell cycle block or apoptosis, and can still can induce Ferroptosis, indicating that the effect of p53 on Ferroptosis is multiple[57].Moreover, Erasatininduced Ferroptosis is not prevented by inhibiting autophagy,apoptosis, or necrosis, suggesting that p53 regulates cysteine uptake to promote Ferroptosis as an effective mechanism[58].

2.5 Others

At present, the study of Ferroptosis related genes such as ACO1,ACSF2, MRP 1 and G6PD is less reported, and the main mechanism is likely to be related to Erastin.Although it may be involved in the occurrence of Ferroptosis, the mechanism of Ferroptosis is unknown and remains to be further verified.

3.Outlook

Research is important in disease treatment.A growing number of basic research has found that inducing or blocking Ferroptosis can affect the occurrence and development of multiple diseases,providing a potential target for treatment, especially for diseases resistant to conventional drugs[59].Take drug resistant cancer,inducing cancer cell death is the therapeutic purpose of many chemotherapy and biotargeted drugs, and cancer cells are prone to form resistance or resistance that drugs cannot kill.But it was found that the resistant cancer cell GPX4 gene is sensitive to Ferroptosis and is targeted to induce cancer cell death[60].Therefore, targeting Ferroptosis provides a new perspective for the treatment of various diseases.

4.Summary

This review mainly addresses the impact of the Ferroptosissensitive related genes of GPX4, FSP1, SLC7A11 and P53 on the development of Ferroptosis.There is a partial understanding of the morphological, biological, and mechanical pathways of cell Ferroptosis, and the different Ferroptosis-sensitive related genes of different cell types.But the trigger process of Ferroptosis sensitive genes involves various mechanisms, the precise regulation of signaling pathway, Ferroptosis and disease, whether and other cell death jointly mediated the progress of the disease, therefore,according to pathological characteristics, targeted trigger Ferroptosis sensitive related gene experimental model, targeted in-depth study of Ferroptosis mechanism, study its role in different disease types,looking for the relevant disease treatment target and targeted drug research and development is of important significance.

Tab2 Summary of GPX4 Inactivation or Loss

Note: VDAC: membrane voltage-dependent anion channel; NF-κB: nuclear factor B, TGF-: transformation growth factor- β,COX-2: epoxoxidase-2; Raf-1:pro-oncoges serine / threonine-protein kinase, B-Raf: serine / threonine rat-filtered sarcoma carcinogenic homologous B1 Gene, FIN56: Ferroptosis Inducer.

Inducers Target mark Function References Mazolone Mostetin An effective, metabolic stability, selective SystemXC-inhibitor, and Ferroptosis inducer [36]AlazSulpyridine An effective, specific NF-B TGF-and COX-2 inhibitor,Inducing Ferroptosis [37]Elastin Induced Ferroptosis by acting on the mitochondrial VDAC [38]Solafini Multiple kinase inhibitors of Raf-1 and B-Raf that activate Ferroptosis [39]Butsteine Sulfonimide Glutamine-cysteineAcid Ligase Lower the cell GSH content [40]Artesunate Glutathione S-Transferase Inhibitors of STAT-3 and output protein 1 (EXP1) that induce Ferroptosis [41]BAY 87-2243 Dehydrogenase Suppresses mitochondrial complex I activity, triggering elevated dependent mitochondrial ROS, resulting in Ferroptosis [42]FIN56 Shalene Synthase Binding and activating Shalene Synthase to inhibit non-steroid metabolites-most likely Coenzyme Q10, -enhanced cell sensitivity to FIN56-induced Ferroptosis [43]

[5] Berry TM, Moustafa AA.A novel treatment strategy to prevent Parkinson's disease: Focus on iron regulatory protein 1 (IRP1).Int J Neurosci 2021, undefined: 1-17.

[6] Mittler R, Darash-Yahana M, Sohn YS, et al.NEET proteins: A new link between iron metabolism, reactive oxygen species, and cancer.Antioxid Redox Signal 2019, 30: 1083-1095.

[7] Song X, Xie Y, Kang R, et al.FANCD2 protects against bone marrow injury from ferroptosis.BiochemBiophys Res Commun 2016, 480: 443-449.

[8] Li X, Si W, Li Z, et al.In vivomiR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in and models of Parkinson's disease.Int J Mol Med 2021, 47(4): 61.

[9] Zhang Z, Yao Z, Wang L, et al.Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.Autophagy 2018, 14: 2083-2103.

[10] Lou JS, Zhao LP, Huang ZH, et al.Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosismediated disruption of the Nrf2/HO-1 axis in EGFR wild-type nonsmall-cell lung cancer.Phytomedicine 2021, 80: 153370.

[11] Yang L, Tian S, Chen Y, et al.Ferroptosis-related gene model to predict overall survival of ovarian carcinoma.J Oncol 2021, 2021: 6687391.

[12]Song J, Liu T, Yin Y, et al.The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity.EMBO Rep 2021, 22:e51162.

[13] Reichert CO, de Freitas FA, Sampaio-Silva J, et al.Ferroptosis mechanisms involved in neurodegenerative diseases.Int J Mol Sci 2020,21(22): 8765.

[14] Alvarez SW, Sviderskiy VO, Terzi EM, et al.NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.Nature 2017, 551: 639-643.

[15] Yang WS, Kim KJ, Gaschler MM, et al.Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.Proc Natl Acad Sci U S A 2016, 113: E4966-75.

[16] Zhao N, Huang Y, Wang YH, et al.Ferronostics: Measuring tumoral ferrous iron with PET to predict sensitivity to iron-targeted cancer therapies.J Nucl Med 2020, 120: 252460.

[17] Yao X, Zhang Y, Hao J, et al.Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis.Neural Regen Res 2019, 14: 532-541.

[18] Xiaofei J , Mingqing S, Miao S, et al.Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.BiochemBiophys Res Commun 2021, 545:81-88.

[19] Zhang X, Tian M, Li X, et al.Hematopoietic protection and mechanisms of ferrostatin-1 on hematopoietic acute radiation syndrome of mice.Int J Radiat Biol 2021, undefined: 1-15.

[20] Sun WY, Tyurin VA, Mikulska-Ruminska K, et al.Phospholipase iPLAβ averts ferroptosis by eliminating a redox lipid death signal.Nat Chem Biol 2021, 17: 465-476.

[21] Zhou H, Yin C, Zhang Z, et al.Proanthocyanidin promotes functional recovery of spinal cord injury via inhibiting ferroptosis.J Chem Neuroanat 2020, 107: 101807.

[22Anthonymuthu TS, Tyurina YY, Sun WY, et al.Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX/PEBP1 complex,suppresses generation of peroxidized ETE-PE, and protects against ferroptosis.Redox Biol 2021, 38: 101744.

[23] Cao JY, Poddar A, Magtanong L, et al.A genome-wide haploid genetic screen identifies regulators of glutathione abundance and ferroptosis sensitivity.Cell Rep 2019, 26: 1544-1556.e8.

[24] Hayano M, Yang WS, Corn CK, et al.Loss of cysteinyl-tRNA synthetase(CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation.Cell Death Differ 2016, 23: 270-278.

[25] Kang YP, Mockabee-Macias A, Jiang C, et al.Non-canonical glutamatecysteine ligase activity protects against ferroptosis.Cell MeTab2021, 33:174-189.e7.

[26] Li J, Lu K, Sun F, et al.Panaxydol attenuates ferroptosis against LPSinduced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway.J Transl Med 2021, 19: 96.

[27] Wu Y, Zhao Y, Yang HZ, et al.HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose.Biosci Rep 2021, 41: (2): BSR20202924.

[28] Li S, Wang M, Wang Y, et al.p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells.Toxicol In Vitro 2021, 73: 105146.

[29] Zhu L, Yang F, Wang L, et al.Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma.Cancer Cell Int 2021, 21: 124.

[30] Niu Y, Zhang J, Tong Y, et al.Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer.Life Sci 2019, 237: 116893.

[31] Zhang K, Wu L, Zhang P, et al.miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma.Mol Carcinog 2018, 57: 1566-1576.

[32] Luo M, Wu L, Zhang K, et al.miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.Cell Death Differ 2018, 25:1457-1472.

[33] Vu kovi AM, Venerando R, Tibaldi E, et al.Aerobic pyruvate metabolism sensitizes cells to ferroptosis primed by GSH depletion.Free Radic Biol Med 2021, 167: 45-53.

[34] Wei Z, Hao C, Huangfu J, et al.Aging lens epithelium is susceptible to ferroptosis.Free Radic Biol Med 2021, 167: 94-108.

[35] Cui W, Liu D, Gu W, et al.Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis.Cell Death Differ 2021, 28(8):2536-2551.

[36] Zhang Y, Tan H, Daniels JD, et al.Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model.Cell Chem Biol 2019, 26: 623-633.e9.

[37] Sugiyama A, Ohta T, Obata M, et al.xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma.Oncol Lett 2020, 20: 2689-2700.

[38] LemastersJJ.Evolution of voltage-dependent anion channel function:from molecular sieve to governator to actuator of ferroptosis.Front Oncol 2017, 7: 303.

[39] Liu X, Zhu X, Qi X, et al.Co-Administration of iRGD with sorafenibloaded iron-Based metal-organic framework as a targeted ferroptosis agent for liver cancer therapy.Int J Nanomedicine 2021, 16: 1037-1050.

[40] Hayashima K, Kimura I, KatohH.Role of ferritinophagy in cystine deprivation-induced cell death in glioblastoma cells.BiochemBiophys Res Commun 2021, 539: 56-63.

[41] Markowitsch SD, Schupp P, Lauckner J, et al.Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis.Cancers (Basel) 2020, 12(11): E3150.

[42] Basit F, van Oppen LM, Schöckel L, et al.Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells.Cell Death Dis 2017, 8:e2716.

[43] Shimada K, Skouta R, Kaplan A, et al.Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis.Nat Chem Biol 2016, 12: 497-503.

[44] Zou Y, Palte MJ, Deik AA, et al.A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis.Nat Commun 2019, 10: 1617.

[45] Thayyullathil F, Cheratta AR, Alakkal Ameeret al.Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis.Cell Death Dis 2021, 12: 26.

[46] Lee N, Carlisle AE, Peppers A, et al.xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers.Antioxidants (Basel) 2021, 10(2): 317.

[47] Doll S, Freitas FP, Shah R, et al.FSP1 is a glutathione-independent ferroptosis suppressor.Nature 2019, 575: 693-698.

[48] Bersuker K, Hendricks JM, Li Z, et al.The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.Nature 2019, 575: 688-692.

[49] Wu WL, PapagiannakopoulosT.The center cannot hold: nRF2 battles ferroptosis in the 3rd dimension.Mol Cell 2020, 80: 760-761.

[50] Zhang Z, Guo M, Shen M, et al.The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells.Redox Biol 2020, 36: 101619.

[51] Liu MR, Zhu WT, Pei DS.SystemXc: a key regulatory target of ferroptosis in cancer.Invest New Drugs 2021, https: //doi.org/10.1007/s10637- 021-01070-0

[52] Wang L, Liu Y, Du T, et al.ATF3 promotes erastin-induced ferroptosis by suppressing system Xc.Cell Death Differ 2020, 27: 662-675.

[53] Kim S, Kang SW, Joo J, et al.Characterization of ferroptosis in kidney tubular cell death under diabetic conditions.Cell Death Dis 2021, 12: 160.

[54] Chen L, Lin Z, Liu L, et al.Fe/Fe ions chelated with ultrasmall polydopamine nanoparticles induce ferroptosis for cancer therapy.ACS Biomater Sci Eng 2019, 5: 4861-4869.

[55] Ying Y, PadanilamBJ.Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis？.Cell Mol Life Sci 2016, 73: 2309-24.

[56] Kang R, Kroemer G, Tang D.The tumor suppressor protein p53 and the ferroptosis network.Free Radic Biol Med 2019, 133: 162-168.

[57] Jiang L, Kon N, Li T, et al.Ferroptosis as a p53-mediated activity during tumour suppression.Nature 2015, 520: 57-62.

[58] Chu B, Kon N, Chen D, et al.ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway.Nat Cell Biol 2019, 21: 579-591.

[59] Xu S, He Y, Lin L, et al.The emerging role of ferroptosis in intestinal disease.Cell Death Dis 2021, 12: 289.

[60] Yang WS, SriRamaratnam R, Welsch ME, et al.Regulation of ferroptotic cancer cell death by GPX4.Cell 2014, 156: 317-331.